Search
Document
UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in Roseville
News
Race-Based Equations May Lead to Under-Treatment of Lung Disease in Black Patients
Using race-based equations to evaluate lung disease -- a practice promoted in the 2019 guidelines of the American Thoracic Society -- may mean that severe lung disease in Black patients is classified as moderate disease, according to a UCSF-led study.
News
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.
News
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
News
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
News
UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.
News
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.
News
UCSF Post-COVID Clinic Treats Long Haulers
UC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.
News
Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.
Document
UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.
News
Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry Device
A new home spirometry kit combines a spirometer with a patient engagement platform to collect lung function data and symptoms remotely. This enables UCSF’s Lung Transplant team to remotely track patients with the goal of identifying both symptomatic and asymptomatic changes in lung function that may be the first sign of early chronic rejection.
Document
Lung Transplant Program
For nine consecutive years, the UCSF Lung Transplant Program has had significantly higher-than-expected post-surgery survival rates — the only program in the country with this record.
